Revisiting the Role of Intravitreal Triamcinolone in Diabetic Macular Edema: 12-Month Outcomes after Bevacizumab Failure

20251 citationsJournal Articlegold Open Access

Authors

Peranut Chotcomwongse · Rangsit University

Paisan Ruamviboonsuk · Rangsit University

Abstract

Repeated IVTA treatments for DME refractory to bevacizumab over a 12-month period demonstrated efficacy and appeared to have a comparable safety profile. Patients with thinner CMT before IVTA treatment had a greater probability of remaining DME-free after IVTA treatment.

Topics & Keywords

Retinal Diseases and Treatments Retinal Imaging and Analysis Retinal and Optic Conditions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Ophthalmology and Therapy

Volume 14, Issue 8, pp. 1755-1772

DOI: 10.1007/s40123-025-01172-5

Field-Weighted Citation Impact: 1.78